Category Archives: Pharmaceuticals

Lilly Alzheimer’s drug, like so many others, fails; will true breakthrough happen this century?

Eli Lilly & Co. (Indianapolis RIN) said its experimental Alzheimer’s treatment failed to slow loss of cognitive ability in patients with mild symptoms, a major setback for the company and millions of… Read more »

Novartis slowly, quietly imploding; will Alcon, Amneal moves halt spiral?

Renewed whispers from Swiss drugmaker Novartis AG (Basel) that it could divest its struggling Alcon eyecare business reflect the latest step in dismantling former leader Dan Vasella’s vision of building… Read more »

New Zika treatment that protects pregnant mice could help protect pregnant women, fetuses; who owns development rights?

In early studies on mice, a research team has found a Zika virus antibody that when given to pregnant animals protected their fetuses, and also protected adult mice from the… Read more »

Mylan discloses two more government probes; posts 3Q loss as EpiPen Woes Persist

The maker of EpiPen emergency allergy injectors, under a microscope for repeatedly hiking the price of the life-saving device, revealed that it’s a target of two price-related probes by federal… Read more »

Valeant stock plunges anew on dismal 3Q results; behold another pharma Sisyphus

After an already noisy year, Valeant Pharmaceuticals International Inc. (Laval Québec) once again took investors off guard–this time, on Election Day–as new management cut the annual profit forecast to well… Read more »

Pfizer misses 3Q views but gets nod for Prevnar from China; Mao would scowl, but not Xi

More than a year after pulling its vaccines out of one of the world’s most challenging but lucrative drug markets, Pfizer has moved back into China with a thumbs up for top-selling… Read more »

Mylan’s EpiPen faces competition from Kaleo Pharma; just what the doctor ordered

Privately held drugmaker Kaleo Inc. (Richmond VA), the main competitor to Mylan NV’s (Amsterdam) EpiPen, announced plans on Wednesday (October 26, 2016) for a US relaunch of its Auvi-Q injector… Read more »

Ariad Pharma’s Slide Continues as Bernie Sanders Seeks Data on Leukemia Drug; Recent Drug Price Hikes Put Company on Familiar Hot Seat

Ariad Pharmaceuticals Inc. (Cambridge MA) continued to plummet Thursday (October 20, 2016) after Vermont Sen. Bernie Sanders and Maryland Rep. Elijah Cummings sent a letter to the company, demanding more information about… Read more »

Johnson & Johnson Tumbles as Pfizer Set to Launch Remicade Biosimilar; Solid 3rd Quarter Doesn’t Quell Market’s Overreaction

Thriving pharmaceutical sales drove stellar quarterly results for Johnson & Johnson (New Brunswick NJ), but the company’s shares fell 3% so far this week on worries that its smash hit,… Read more »

Healthcare Stocks Tumble as Clinton’s Lead Widens; Are the Jitters Justified or Do Opportunities Abound?

Democratic presidential nominee Hillary Clinton has been named the culprit for beating down biotech stocks just for squealing about high drug prices on Twitter. Imagine the ever-increasing likelihood of her becoming the… Read more »